SAVA

Cassava Sciences, Inc.

10.05 USD
-0.03 (-0.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cassava Sciences, Inc. stock is down -49.7% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.67% of the previous 24 July’s closed higher than June. In the last 10 Unusual Options Trades, there were 3 CALLs, 7 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
17 Jul 14:07 30 Aug, 2024 6.00 CALL 200 0
17 Jul 14:12 19 Jul, 2024 10.00 PUT 200 1271
17 Jul 14:42 16 Jan, 2026 35.00 CALL 100 2797
17 Jul 14:52 15 Nov, 2024 10.00 CALL 100 126
17 Jul 16:38 17 Jan, 2025 15.00 PUT 100 470
17 Jul 18:43 16 Aug, 2024 10.00 PUT 172 2717
17 Jul 18:43 16 Aug, 2024 10.00 PUT 459 2717
18 Jul 14:02 16 Aug, 2024 10.00 PUT 800 3406
18 Jul 14:57 16 Jan, 2026 10.00 PUT 50 59
19 Jul 19:33 26 Jul, 2024 11.00 PUT 200 42

About Cassava Sciences, Inc.

Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial.

  • Jones Trading
    Mon Jul 1, 10:11
    hold
    downgrade
  • HC Wainwright & Co.
    Mon Jul 1, 07:02
    hold
    downgrade